迈科康生物 迈科康生物

CN

1st launch in China, new technology route | MaxHealth's recombinant rotavirus subunit vaccine program enters clinical trials stage

HIT:417

1st launch in China, new technology route | MaxHealth's recombinant rotavirus subunit vaccine program enters clinical trials stage